Clinical Add‐on: Multiple sclerosis – clinical picture and therapeutic strategies

Abstract

Multiple Sclerosis is a chronic inflammatory disorder of the central nervous system, affecting up to 1.5 % of the population in the US, UK, or Germany. Various subtypes exhibit different patterns of myelin or axonal damage and different stages of inflammation and neurodegeneration. The clinical pictures vary from rare attacks to chronically progressive disability. Current treatment options are mainly immunosuppressive or immunomodulatory [1].